Objective: A monkey model of the menopausal transition (perimenopause) would facilitate efforts to understand better the effect of hormonal fluctuations during this life phase on the initiation of chronic diseases associated with the postmenopausal years. Antimüllerian hormone (AMH) is a promising marker of ovarian reserve (primordial follicle number) in women. Here, we describe the relationship between AMH and ovarian reserve in cynomolgus monkeys (Macaca fascicularis) estimated to be 12 to 15 years of age (È36<45 y in women).
N onhuman primates, especially macaque monkeys, have long served as a model for understanding both the reproductive biology of women and the health of women in relation to reproductive stage and hormone exposure. Because natural menopause occurs in numerous monkey species [including rhesus and cynomolgus macaques (Macaca mulatta and Macaca fascicularis, respectively)] and results in hormonal profiles resembling those of women, it seems reasonable to extend biomedical investigations in monkeys to the perimenopausal transition and menopause. 1, 2 However, studies focused on the hormonal disruption and presumed increased vulnerability to chronic disease characteristic of the perimenopausal transition and early menopause have heretofore been limited by the inability to assess ovarian reserve noninvasively and thereby identify potential subjects for further investigation. 3 Serum antimüllerian hormone (AMH) is becoming increasingly prominent as a noninvasive marker of ovarian reserve in women and might, by extension, be used similarly in monkeys. Antimüllerian hormone is produced by granulosa cells of small growing (preantral and small antral) follicles in the ovaries of rodents and nonhuman and human primates. 4<7 Women experience declining AMH values as they transition to menopause, suggesting that AMH is a reliable marker of ovarian reserve (primordial follicle number) and that it might eventually be used to predict the onset of menopause. 8<12 Finally, AMH concentrations fall to undetectable levels in naturally and surgically postmenopausal women. 13, 14 In this report, we describe for the first time the relationship among AMH concentrations, menstrual cycle stage, and follicle numbers in cynomolgus monkeys.
METHODS

Animals
Three studies are described, all of which made use of animals assigned to the control groups of ongoing studies:
Characterization of AMH across the menstrual cycle. Twelve Indonesian-origin female monkeys were used with an average age of È12 to 15 years (determined by radiographic evidence of complete epiphyseal closure at the distal radius, ulna, and the proximal tibia), which equates to È36 to 45 years in women. Monkeys were housed in groups of four and underwent daily vaginal swabbing for 12 weeks to detect menstrual bleeding. In addition, blood samples were collected three times per week (without anesthesia) for measurement of AMH, estradiol (E 2 ), progesterone (P 4 ), and follicle-stimulating hormone (FSH). Determination of the source of AMH production in the monkey. AMH was measured in Chinese-origin monkeys (È7 y of age, equivalent to 21 y in women) before and after unilateral ovariectomy (n = 19) and in Indonesianorigin monkeys (12-15 y of age) before and after complete ovariectomy (n = 84).
Determination of the association between AMH and follicle number. Indonesian monkeys aged 12 to 15 years (n = 29) that had been consuming an isoflavone-free, humanlike diet for 3 years 15 were ovariectomized, and their ovaries were fixed for histological evaluation. Antimüllerian hormone was measured from samples taken at the time of ovariectomy.
All animal manipulations were approved by the Wake Forest University Animal Care and Use Committee and were conducted in accordance with state and federal laws and following the guidelines of the US Department of Health and Human Services.
Hormone assays
Serum AMH was measured using an enzyme-linked immunosorbent assay (DSL, Texas), and the coefficients of variation (CVs) were as follows: intra-assay CV, 4.53% at 13.62 ng/mL; interassay CV, 19.75% at 0.23 ng/mL, 11.42% at 9.61 ng/mL, and 11.27% at 1.89 ng/mL. It should be noted that two commercial assays are available to measure AMH, and a recent study that compared them in women found that the AMH concentration was È4.6-fold lower in samples assayed with the DSL enzyme-linked immunosorbent assay than in those assayed with the ultrasensitive Immunotech-Coulter assay (Marseilles, France). 16 E 2 17 and P 4 18 were measured using modifications of commercially available kits from Diagnostic Products Corporation (Los Angeles, CA). Intra-assay and interassay CVs were less than 4% and 10%, FIG. 1. A: Representative graph of serum estradiol (E 2 ; left axis), antimüllerian hormone (AMH), progesterone (Prog), and follicle-stimulating hormone (FSH) concentrations (right axis) across an ovulatory menstrual cycle of a cynomolgus monkey. Monkeys were swabbed daily to detect menses (dashed box), and blood was collected three times a week (Monday, Wednesday, and Friday) for 12 weeks for AMH measurement. B: Concentration of AMH before and after ovulation (Ov) in 12 cynomolgus monkeys of estimated age of 12 to 15 years. A total of 18 ovulatory cycles were included in the analysis, and data are shown as mean T SE for each cycle day relative to the day of ovulation (determined by FSH peak). respectively. FSH was measured with a radioimmunoassay using macaque primary antibodies (Wisconsin National Primate Research Center), and intra-assay and interassay CVs were 3.49% and 9.33%, respectively.
Ovarian follicle counts
Both ovaries were removed, trimmed of fat, weighed, and fixed in Bouin's solution (75 mL picric acid solution [1.3%], 25 mL formaldehyde [37%], and 5 mL glacial acetic acid) for 24 hours and then transferred to 70% ethanol. One ovary from each monkey was transferred to the University of Arizona for follicle counting (P.B.H. and P.J.C.) using methods published previously. 19 Briefly, the entire ovary was sectioned serially (4-5 Km) and stained with hematoxylin and eosin. Follicles were classified as primordial (oocytes surrounded by a single layer of flattened granulosa cells), primary (oocyte surrounded by a single layer of cuboidal granulosa cells), and secondary (oocytes surrounded by two or more layers of cuboidal granulosa cells) and counted in every 100th section to avoid double counting of small preantral follicles. Only follicles with an oocyte nucleus were counted. Data are recorded as total follicles counted per ovary.
Statistical analysis
In experiment 1, we used a general linear mixed effect model to assess the concentration of AMH across the menstrual cycles. Least-square means were reported graphically for the different time points. The Tukey pairwise comparison procedure was used to identify where significant differences exist across the menstrual cycles, and the intraclass correlation was reported. In experiment 2, the AMH concentration before and after removal of ovaries was reported as means T SE. Paired t tests were used to determine significance of differences in mean AMH before and after the removal of ovaries. In experiment 3, we used Pearson's correlation coefficients and linear regression models to examine the associations between follicle types and AMH. The outcome variables (the primordial, primary, and secondary follicle counts) were square-root transformed to achieve better normality and equality of variance assumptions. The regression coefficients and the corresponding 95% CIs are reported. All analyses were performed using SAS v9.1.3 (SAS Institute, Cary, NC). Significance was assigned at P G 0.05.
RESULTS
AMH across the menstrual cycle
As shown in Fig. 1A , AMH is relatively stable across the menstrual cycle (intraclass correlation is È0.8) of cynomolgus monkeys, especially in comparison with the large variation apparent in E 2 , P 4 , and FSH concentrations. Nonetheless, analysis of the AMH concentration across 18 menstrual cycles (from 12 monkeys) revealed that there is a slight (È1.4-fold) although significant variation, with the lowest concentrations of AMH occurring 2 to 5 days after ovulation (P G 0.02 for difference in AMH concentration between days j19 and days 2 and 5, relative to ovulation; Fig. 1B ). In addition, there was substantial interindividual variation in AMH among the 12 monkeys studied, with the mean AMH per monkey (across a mean of 1.75 cycles) ranging from 4.46 T 0.17 to 18.80 T 0.71 ng/mL. Among the 12 monkeys, mean E 2 concentrations ranged from 2.86 to 475 pg/mL (midcycle peak), P 4 ranged from 0.54 to 11.58 ng/mL, and FSH ranged from 0.17 to 4.56 ng/mL. 
Source of AMH
The source of AMH production in premenopausal monkeys was determined by comparing mean AMH concentrations in premenopausal monkeys (age 7 y) before and after the removal of one ovary (7.6 T 0.77 to 2.75 T 0.37 ng/mL, P G 0.001) and premenopausal monkeys (age 12<15 y) before and after the removal of both ovaries (5.8 T 0.42 to G0.05 ng/mL, P G 0.001). Figure 2A shows that removal of one ovary results in a È63% reduction in AMH, and AMH was undetectable after bilateral ovariectomy.
AMH and follicle number
The relationship between AMH and primordial, primary, and secondary follicles in the monkey ovary was examined. Significant correlations were seen between AMH and primordial (r = 0.78, P G 0.001), primary (r = 0.66, P = 0.001), and secondary (r = 0.80, P G 0.001) follicles (Fig. 2B,  C and D) . The regression (A) coefficients for the association between primordial, primary, and secondary follicles and AMH were also significant (P G 0.001) and were as follows, respectively: 4.16 (95% CI, j2.85 to 5.48), 0.47 (95% CI, j0.25 to 0.68), and 0.57 (95% CI, j0.39 to 0.74).
DISCUSSION
The data presented here suggest that, in monkeys, AMH is relatively stable across the menstrual cycle, the ovary is most likely the main source of AMH, and the relationship between AMH and ovarian reserve is similar to the positive association observed in women.
Analysis of 18 ovulatory cycles indicated that AMH was relatively stable across the menstrual cycle in monkeys, especially in comparison with the large (up to 50-fold) variation apparent in E 2 , P 4 , and FSH concentrations. A slight but significant intracycle variation (È1.4-fold) was observed, however, with the lowest values occurring in the early luteal phase. Several studies of women (aged 24<38 y) have reported that cyclic variations in AMH do not occur, 20<23 although intracycle AMH variations of 14% to 17% were observed, presumably due to continuous, noncyclic growth of follicles. In contrast, a periovulatory rise in AMH has been reported in two studies. 24, 25 In one of those studies, young women (aged 23 y, n = 36) were sampled intensively across the menstrual cycle, and a 25% intracycle variability in AMH was observed, with maximal concentrations in the late follicular phase and declines in the early luteal phase. 25 It is important to note that although statistically significant, the absolute changes in AMH were small. Furthermore, although our data in monkeys and studies of women suggest that there may be some variation in AMH across the menstrual cycle, this should be interpreted within the context of the extremely large cyclic variations in E 2 and FSH. Thus, for purposes of determination of ovarian reserve in middle-aged women and monkeys, AMH can be sampled without reference to cycle day.
Our finding that AMH concentrations are reduced by more than 50% after unilateral ovariectomy and reduced below the level of detection after the removal of both ovaries suggests that, as in women, the ovary is most likely the sole source of AMH in the monkey. This finding is supported by studies in women showing that AMH is not detectable in both naturally and surgically postmenopausal women. 13, 14 In women, the reproductive events leading to the perimenopausal transition and culminating in menopause are the direct consequence of declining numbers of ovarian primordial follicles. 26 The age at which follicular depletion occurs can vary from È40 to 60 years and presumably reflects the variation in rate of follicle loss. 27 Similarly, monkeys experience a decline in primordial follicle counts with age and are essentially devoid of follicles at menopause. 28 Our data suggest that, as in women, AMH is highly correlated with follicle number in monkeys, indicating that AMH could be used to identify monkeys with low ovarian reserve. In support of our findings in cynomolgus monkeys is a recent study of rhesus macaques, in which older monkeys (È24 y) that were still cycling regularly could be classified as perimenopausal according to their low AMH and high FSH concentrations. 29 Follicle counts were not reported in that study, but our data would suggest that those monkeys had decreased numbers of primordial, primary, and secondary follicles and would soon become menopausal.
Finally, we report significant interindividual variation in AMH in monkeys, and this is similar to what has been reported in women. 20<25 Our data relating AMH to follicle number suggest that this variation is due to variation in follicle number among the monkeys, which in turn may be related to the variation in age. However, because the age of the monkeys is estimated using dentition and physeal closure, we cannot test this hypothesis using statistical means, and future investigations of AMH concentrations across a wider age range than was available in this opportunistic assessment are needed.
CONCLUSIONS
The relationship between AMH and ovarian reserve in monkeys is nearly identical to that in women. This finding, along with the many other reproductive similarities between monkeys and women (similar menstrual cycle patterns and hormonal fluctuations, endometrial sloughing, etc), makes this species (and probably its close relatives) a potentially useful model for studying the effect of hormonal fluctuations across the menopausal transition on disease processes later in life.
